Cochlear reported $617.8M in Gross Profit on Sales for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Ansell ANN:AU $ 325.4M 106.4M
Cochlear COH:AU $ 617.8M 60.9M
CSL CSL:AU $ 3.45B 1.08B
Estia Health EHE:AU $ 311.38M 16.78M
Fisher Paykel Healthcare FPH:NZ 485M 82.7M
Healius Ltd HLS:AU $ 1.16B 352.6M
Integral Diagnostics Ltd IDX:AU 172.23M 2.04M
Mayne Pharma MYX:AU $ 93.04M 6.59M
Monash IVF Group Ltd MVF:AU 90.98M 7.23M
Nanosonics Ltd NAN:AU $ 46.4M 259K
Polynovo Ltd PNV:AU 15.77M 3.94M
Ramsay Health Care RHC:AU $ 4.68B 100.5M
ResMed RMD:AU $ 491.2M 13.12M
Sigma Healthcare Ltd SIG:AU 171.24M 1.23M
Somnomed Ltd SOM:AU 20.93M 1.27M
Sonic Healthcare SHL:AU $ 3.95B 409.81M
Telix Pharmaceuticals Ltd TLX:AU 3.01M 978K
Virtus Health VRT:AU 122.23M 10.48M